Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-05-27 @ 8:06 PM
Study NCT ID:
NCT01270958
Status:
COMPLETED
Last Update Posted:
2014-08-06
First Post:
2010-08-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis
Sponsor:
GlaxoSmithKline
Organization: